Details of the Drug

General Information of Drug (ID: DM0L8R9)

Drug Name
ORIC-944
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 1 [1]
Drug Type
Small molecule
Cross-matching ID
PubChem CID
155788096
TTD ID
DPS29T

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Embryonic ectoderm development protein (EED) TTFNJ4R EED_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05413421) An Open-Label, Phase 1/1b, Study of ORIC-944 in Patients With Metastatic Prostate Cancer. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of ORIC Pharmaceuticals